AGAM
Avalon Global Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-23,060
| Closed | -$3.3M | – | 32 |
|
|
2019
Q1 | $3.3M | Sell |
23,060
-5,000
| -18% | -$715K | 1.76% | 23 |
|
|
2018
Q4 | $3.48M | Buy |
28,060
+930
| +3% | +$115K | 2.11% | 19 |
|
|
2018
Q3 | $4.56M | Hold |
27,130
| – | – | 1.57% | 19 |
|
|
2018
Q2 | $4.67M | Hold |
27,130
| – | – | 1.7% | 18 |
|
|
2018
Q1 | $4.1M | Buy |
27,130
+5,000
| +23% | +$755K | 1.41% | 19 |
|
|
2017
Q4 | $2.98M | Hold |
22,130
| – | – | 1.48% | 26 |
|
|
2017
Q3 | $3.24M | Hold |
22,130
| – | – | 1.23% | 21 |
|
|
2017
Q2 | $3.44M | Sell |
22,130
-5,000
| -18% | -$777K | 1.92% | 20 |
|
|
2017
Q1 | $3.94M | Buy |
27,130
+12,500
| +85% | +$1.81M | 2.05% | 14 |
|
|
2016
Q4 | $1.6M | Sell |
14,630
-12,870
| -47% | -$1.4M | 1.31% | 28 |
|
|
2016
Q3 | $3.34M | Buy |
27,500
+5,000
| +22% | +$607K | 2% | 21 |
|
|
2016
Q2 | $3.18M | Sell |
22,500
-2,500
| -10% | -$353K | 1.84% | 16 |
|
|
2016
Q1 | $3.26M | Buy |
+25,000
| New | +$3.26M | 2.47% | 13 |
|